X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9559) 9559
Newsletter (455) 455
Newspaper Article (239) 239
Magazine Article (58) 58
Book Chapter (40) 40
Dissertation (11) 11
Publication (8) 8
Book Review (5) 5
Transcript (5) 5
Book / eBook (4) 4
Conference Proceeding (2) 2
Web Resource (2) 2
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
adalimumab (8754) 8754
humans (6626) 6626
infliximab (4362) 4362
female (3894) 3894
male (3668) 3668
adult (2996) 2996
middle aged (2994) 2994
tumor necrosis factor-alpha - antagonists & inhibitors (2860) 2860
etanercept (2723) 2723
treatment outcome (2393) 2393
rheumatology (2340) 2340
antibodies, monoclonal - therapeutic use (2149) 2149
rheumatoid arthritis (1940) 1940
arthritis, rheumatoid - drug therapy (1849) 1849
antirheumatic agents - therapeutic use (1843) 1843
antibodies, monoclonal, humanized (1691) 1691
therapy (1567) 1567
aged (1467) 1467
psoriasis (1380) 1380
gastroenterology & hepatology (1364) 1364
dermatology (1351) 1351
antibodies, monoclonal, humanized - therapeutic use (1322) 1322
efficacy (1246) 1246
adalimumab - therapeutic use (1193) 1193
double-blind (1177) 1177
rheumatoid-arthritis (1172) 1172
care and treatment (1167) 1167
arthritis (1133) 1133
anti-inflammatory agents - therapeutic use (1063) 1063
methotrexate (1052) 1052
crohn's disease (1046) 1046
severity of illness index (1025) 1025
crohn disease - drug therapy (1020) 1020
safety (1004) 1004
tumor necrosis factor (989) 989
antibodies, monoclonal - adverse effects (974) 974
drug therapy (922) 922
immunoglobulin g - therapeutic use (905) 905
receptors, tumor necrosis factor - therapeutic use (904) 904
psoriasis - drug therapy (880) 880
young adult (871) 871
retrospective studies (866) 866
antirheumatic agents - adverse effects (829) 829
pharmacology & pharmacy (823) 823
crohns-disease (799) 799
inflammatory-bowel-disease (782) 782
inflammatory bowel disease (766) 766
research (766) 766
adolescent (744) 744
drug therapy, combination (708) 708
tumor necrosis factor-tnf (695) 695
monoclonal antibodies (683) 683
analysis (671) 671
medicine & public health (661) 661
ulcerative colitis (652) 652
rheumatoid factor (640) 640
patients (632) 632
medical research (602) 602
abridged index medicus (601) 601
methotrexate - therapeutic use (594) 594
disease (591) 591
infliximab - therapeutic use (587) 587
antibodies, monoclonal, humanized - adverse effects (579) 579
risk factors (564) 564
medicine, experimental (558) 558
remission (541) 541
immunosuppressive agents - therapeutic use (540) 540
immunology (530) 530
time factors (530) 530
follow-up studies (517) 517
remission induction (511) 511
prospective studies (505) 505
medicine, general & internal (492) 492
clinical trials (488) 488
monoclonal-antibody (484) 484
trial (472) 472
certolizumab pegol (468) 468
biological products - therapeutic use (466) 466
antibodies, monoclonal - administration & dosage (463) 463
inflammation (460) 460
adalimumab - adverse effects (458) 458
anti-inflammatory agents - adverse effects (451) 451
arthritis, psoriatic - drug therapy (436) 436
health aspects (435) 435
antibodies (434) 434
biologics (434) 434
dosage and administration (430) 430
management (426) 426
antirheumatic agents - administration & dosage (424) 424
psoriatic arthritis (424) 424
anti-tnf (421) 421
quality of life (417) 417
ankylosing spondylitis (411) 411
immunotherapy (410) 410
child (404) 404
tumor necrosis factor-alpha - immunology (404) 404
immunoglobulin g - adverse effects (402) 402
risk (390) 390
necrosis-factor-alpha (382) 382
inflammatory bowel diseases - drug therapy (377) 377
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9492) 9492
Spanish (201) 201
German (178) 178
French (161) 161
Korean (78) 78
Japanese (77) 77
Russian (47) 47
Portuguese (40) 40
Polish (37) 37
Italian (35) 35
Hungarian (28) 28
Danish (19) 19
Czech (17) 17
Turkish (17) 17
Chinese (12) 12
Croatian (12) 12
Dutch (8) 8
Swedish (5) 5
Slovak (4) 4
Finnish (2) 2
Serbian (2) 2
Arabic (1) 1
Hebrew (1) 1
Norwegian (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Alimentary pharmacology & therapeutics, ISSN 0269-2813, 2017, Volume 46, Issue 9, pp. 873 - 882
Summary Background Significance of monitoring adalimumab trough levels and anti‐adalimumab antibodies (AAA) for disease outcome in Crohn's disease (CD)... 
RHEUMATOID-ARTHRITIS | MAINTENANCE | INFLAMMATORY-BOWEL-DISEASE | 6-THIOGUANINE NUCLEOTIDE | IMMUNOMODULATORS | COMBINATION THERAPY | ULCERATIVE-COLITIS | RANDOMIZED-TRIAL | PHARMACOLOGY & PHARMACY | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-RESPONSE | Guanine Nucleotides - blood | Adalimumab - immunology | Thionucleotides - blood | Humans | Anti-Inflammatory Agents - immunology | Male | Treatment Outcome | Crohn Disease - immunology | Anti-Inflammatory Agents - blood | Adalimumab - therapeutic use | Mercaptopurine - therapeutic use | Adalimumab - blood | Crohn Disease - blood | Crohn Disease - drug therapy | Sensitivity and Specificity | Adalimumab - pharmacokinetics | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - pharmacokinetics | Antibodies - blood | Female | Drug Therapy, Combination | Mercaptopurine - analogs & derivatives | Measurement | Viral antibodies | Medical research | Analysis | Medicine, Experimental | Antibodies | Biopharmaceutics | Blood cells | Body weight | Erythrocytes | Diamonds | Crohn's disease | Pharmacology | Regression analysis | Thioguanine | Patients | Crohns disease | Sensitivity | Regression models | Red blood cells | Multiple regression models | Predictions | Monoclonal antibodies | Remission | Pharmacokinetics | Original | Personalised Adalimumab Pharmacokinetics
Journal Article
Journal Article
Revista española de enfermedades digestivas, ISSN 1130-0108, 09/2019, Volume 111, Issue 9, p. 721
Journal Article
Journal Article
Gut, ISSN 0017-5749, 01/2018, Volume 67, Issue 1, pp. 53 - 53
ObjectiveThe efficacy of anti-tumour necrosis factors (anti-TNFs) in patients with Crohn's disease (CD) and symptomatic small bowel stricture (SSBS) is... 
FIBROSIS | ENTEROGRAPHY | ENTEROCLYSIS | TRIALS | THERAPY | INFLAMMATION | CONSENSUS | INDEX | INFLIXIMAB | GASTROENTEROLOGY & HEPATOLOGY | LESIONS | Prognosis | Prospective Studies | Humans | Middle Aged | Male | Intestinal Obstruction - diagnostic imaging | Adalimumab - adverse effects | Crohn Disease - complications | Adult | Female | Severity of Illness Index | Intestinal Obstruction - etiology | Crohn Disease - diagnostic imaging | Drug Administration Schedule | Treatment Outcome | Magnetic Resonance Imaging | Adalimumab - therapeutic use | Intestinal Obstruction - drug therapy | Adalimumab - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Crohn Disease - drug therapy | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Intestine, Small - diagnostic imaging | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Treatment outcome | Care and treatment | Dosage and administration | Crohn's disease | Adalimumab | Analysis | Corticoids | Nuclear magnetic resonance--NMR | Medical imaging | Clinical trials | Stenosis | Systematic review | Inflammation | Patients | Success | Abdomen | Crohns disease | Inflammatory bowel disease | Pain | Intestine | Surgery | Gangrene | Monoclonal antibodies | Tumor necrosis factor-TNF | Endoscopy | Cancer | Tumors | Index Medicus | Abridged Index Medicus | Life Sciences | Human health and pathology | Hépatology and Gastroenterology | Immunology | Immunotherapy | ABDOMINAL MRI | CROHN'S DISEASE | Inflammatory Bowel Disease | 1506 | IBD CLINICAL
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 11/2013, Volume 13, Issue 11, pp. 1599 - 1611
Introduction: Following its marketing authorization for the treatment of ankylosing spondylitis (AS) in 2006 in the United States und in the European Union,... 
nonradiographic axial spondyloarthritis | tumor necrosis factor α | adalimumab | ankylosing spondylitis | Adalimumab | Nonradiographic axial spondyloarthritis | Ankylosing spondylitis | Tumor necrosis factor α | MEDICINE, RESEARCH & EXPERIMENTAL | FACTOR ANTAGONIST THERAPY | SHORT-TERM IMPROVEMENT | OF-LIFE OUTCOMES | SOCIETY CLASSIFICATION CRITERIA | RADIOGRAPHIC PROGRESSION | RHEUMATOLOGY BIOLOGICS REGISTER | TNF-ALPHA INHIBITORS | tumor necrosis factor alpha | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | OPEN-LABEL TRIAL | PLACEBO-CONTROLLED TRIAL | NECROSIS-FACTOR BLOCKERS | Spondylarthritis - diagnostic imaging | Clinical Trials as Topic - statistics & numerical data | Antirheumatic Agents - administration & dosage | United States | Humans | Spondylarthritis - drug therapy | Spondylarthritis - pathology | Biological Products - pharmacology | Drug Approval | Infection - etiology | Antibodies, Monoclonal, Humanized - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacology | Antirheumatic Agents - adverse effects | Biological Products - adverse effects | Antirheumatic Agents - pharmacology | Spine - pathology | Antirheumatic Agents - therapeutic use | Biological Products - therapeutic use | Antibodies, Monoclonal, Humanized - adverse effects | Multicenter Studies as Topic - statistics & numerical data | Randomized Controlled Trials as Topic - statistics & numerical data | Antibodies, Monoclonal, Humanized - therapeutic use | Disease Susceptibility | Double-Blind Method | Spondylitis, Ankylosing - drug therapy | Treatment Outcome | Disease Progression | Spondylitis, Ankylosing - diagnostic imaging | Radiography | Spine - diagnostic imaging | European Union | Biological Products - administration & dosage | Spondylitis, Ankylosing - pathology | Tumor Necrosis Factor-alpha - antagonists & inhibitors
Journal Article